Results 221 to 230 of about 131,342 (265)
Some of the next articles are maybe not open access.

Thrombotic Microangiopathy in Cancer

Seminars in Thrombosis and Hemostasis, 2018
AbstractThrombotic microangiopathy (TMA) is a rare but often devastating complication of cancer and cancer treatment. The syndrome is defined by thrombocytopenia (i.e., a platelet count of < 150,000/mcL or > 30% decrease from baseline), microangiopathic hemolytic anemia, and some evidence of organ damage.
openaire   +3 more sources

[Thrombotic microangiopathy].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023
In the emergency room, patients with anemia and thrombocytopenia are common. Although these findings can often be explained by the medical situation, thrombotic microangiopathy is an important differential diagnosis. In this case, occlusion of the smallest vessels consequently leads to functional impairment of the affected organs.
Tilman, Schmidt, Tobias B, Huber
openaire   +1 more source

[Thrombotic microangiopathy].

Der Internist, 2013
Thrombotic microangiopathy should be suspected every time the combination of microangiopathic hemolytic anemia without a coexisting cause, thrombocytopenia as well as renal and/or neurologic abnormalities occurs. The general term thrombotic microangiopathy includes different subtypes of the disease leading to abnormalities in multiple organ systems by ...
Ganser, A., Kielstein, J. T., Beutel, G.
openaire   +2 more sources

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

Thrombosis and Haemostasis, 2020
Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of allogeneic hematopoietic cell transplantation (HCT).
E. Gavriilaki   +23 more
semanticscholar   +1 more source

Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.

Seminars in Arthritis & Rheumatism, 2019
INTRODUCTION Thrombotic microangiopathy (TMA) is a life-threatening, albeit infrequent, complication of systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS).
N. Kello   +5 more
semanticscholar   +1 more source

[Thrombotic microangiopathy].

Der nephrologe
Thrombotic microangiopathy (TMA) is characterized by an endothelium injury-associated formation of platelet clots in arterial and venous microvessels. Concomitant ischemia causes severe organ dysfunction and can be acutely life threatening. The underlying etiology of TMA shows a very heterogeneous disease spectrum.
Anja, Gäckler, Oliver, Witzke
openaire   +3 more sources

[Thrombotic Microangiopathies].

Deutsche medizinische Wochenschrift (1946), 2018
Thrombotic microangiopathies are almost devastating diseases leading to death at high frequency if untreated. They consist of at least five distinct entities, TTP, HUS, aHUS, TMA due to drug interference, systemic disease or post therapy TMA. Around 10 years ago there was only one established therapeutic approach as plasmapheresis. Meanwhile, there are
Jörg, Schubert, Michael, Dechant
openaire   +1 more source

Thrombotic microangiopathies

Critical Reviews in Oncology/Hematology, 1991
P, Ruggenenti, G, Remuzzi
openaire   +2 more sources

Home - About - Disclaimer - Privacy